pCI-HA-mAVO3 (pRL62-3) Citations (1)
Originally described in: Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A, Hall MN Nat Cell Biol. 2004 Nov;6(11):1122-8. Epub 2004 Oct 3. PubMed Journal
Articles Citing pCI-HA-mAVO3 (pRL62-3)
| Articles |
|---|
| Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis. Morrison Joly M, Williams MM, Hicks DJ, Jones B, Sanchez V, Young CD, Sarbassov DD, Muller WJ, Brantley-Sieders D, Cook RS. Breast Cancer Res. 2017 Jun 30;19(1):74. doi: 10.1186/s13058-017-0868-8. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.